Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Cancer Investigation|January 1, 1996
Hydroxyurea may increase the activity of fluorouracil plus folinic acid in advanced gastrointestinal cancer: phase II studyF Di Costanzo, H el-Taani, D Parriani, et al.
Oncology Reports|August 10, 2001
Gemcitabine plus epirubicin in advanced pancreatic cancer: a phase II multicenter trialG P Ianniello, M Orditura, A Rossi, et al.
Tumori|April 25, 2000
Concurrent modulation of 5-fluorouracil with methotrexate and L-leucovorin: an effective and moderately toxic regimen for the treatment of advanced colorectal carcinoma. A multicenter phase II study of the Southern Italy Cooperative Oncology GroupP Comella, V Lorusso, R Casaretti, et al.
Breast Cancer Research and Treatment|July 29, 1999
Dose intensification of mitoxantrone in combination with paclitaxel in advanced breast cancer: a phase II studyF D Costanzo, A Sdrobolini, L Manzione, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2003
Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patientsD Lorusso, G Ferrandina, S Greggi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2005
FOLFIRI regimen in advanced colorectal cancer: the experience of the Gruppo Oncologico dell'Italia Meridionale (GOIM)E Maiello, V Gebbia, F Giuliani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2000
Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase I-II trial of the Southern Italy Cooperative Oncology Group (SICOG)F Caponigro, P Comella, F Rivellini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck: a phase II study of the Southern Italy Cooperative Oncology Group (SICOG)F Caponigro, E Massa, L Manzione, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2001
Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trialC Gridelli, S Cigolari, C Gallo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 5, 2003
An escalating dose finding study of liposomal doxorubicin and vinorelbine for the treatment of refractory or resistant epithelial ovarian cancerR Tambaro, S Greggi, R V Iaffaioli, et al.
Pageof 5